Benefit‐risk of tofacitinib in patients with moderate to severe chronic plaque psoriasis: Pooled analysis across 6 clinical trials

British Journal of Dermatology, Volume 0, Issue ja, -Not available-.


https://ift.tt/2MVEVYL